Amid the news of a $23-million court settlement by the makers of Airborne — a supplement that's earned hundreds of millions of dollars in sales with the claim that it boosts the immune system — biomedical engineers are publishing research on a powder that could turn out to be the real thing. As this ScienCentral News video explains, the new powder could first be used to help fight cancer.
| |
| Interviewee: Tarek Fahmy, Yale University |
Posts
No comments:
Post a Comment